Effects of Nordic Walking on Prenatal Health
Launched by UNIVERSITY OF JAZAN · Nov 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of Nordic walking on the health of pregnant women. Specifically, it aims to see how this type of walking can improve movement, reduce muscle and joint pain, and enhance overall quality of life for women who are expecting. Nordic walking involves using special poles to help with balance and support while walking, making it a safe and effective form of exercise.
To participate in the study, women need to be healthy, aged between 20 and 40 years, and between 13 to 28 weeks pregnant with a single baby. They should be experiencing some mild to moderate discomfort, like back or pelvic pain, but must not have any serious health issues that could affect their bones or nerves. Participants should have the green light from their doctor to exercise during pregnancy and be able to engage in moderate physical activity. If you’re eligible and decide to join, you'll be guided through the walking sessions and monitored to see how this activity benefits your pregnancy experience.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy women aged 20 to 40 between 13 and 28 weeks into singleton pregnancy.
- • Participants must be experiencing mild to moderate musculoskeletal discomfort, such as lower back or pelvic pain,
- • Participants have no prior musculoskeletal or neurological diseases.
- • They must have no contraindications to exercising throughout pregnancy, as established by obstetrician clearance, and be able to engage in moderate physical activity under medical recommendations
- Exclusion Criteria:
- • History of diseases affecting bony structures or lumbar intervertebral discs.
- • Pain caused by non-musculoskeletal factors (such as urinary tract infections or obstetric complications).
- • Multiple pregnancies, pre-existing mobility conditions, and high-risk pregnancies or complications that restrict physical activity.
About University Of Jazan
The University of Jazan is a leading academic institution in Saudi Arabia dedicated to advancing healthcare research and education. With a strong emphasis on clinical trials, the university aims to enhance medical knowledge and improve patient outcomes through innovative studies. The institution fosters collaboration between multidisciplinary teams of researchers, healthcare professionals, and students, ensuring a rigorous and ethical approach to clinical research. By leveraging its state-of-the-art facilities and expertise, the University of Jazan is committed to contributing valuable insights to the global medical community and addressing pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Riyadh, Alkharj, Saudi Arabia
Patients applied
Trial Officials
Nadia L Radwan, PHD
Study Director
Prince Sattam Bin Abdulaziz University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported